157 related articles for article (PubMed ID: 33941865)
1. Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer.
Asiri IM; Chen RC; Young HN; Codling J; Mandawat A; Beach SRH; Master V; Rajbhandari-Thapa J; Cobran EK
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1093-1102. PubMed ID: 33941865
[TBL] [Abstract][Full Text] [Related]
2. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment.
Yeboa DN; Guzzo T; Mitra N; Christodouleas JP; Haas NB; Vapiwala N; Armstrong K; Bekelman JE
Urology; 2011 Nov; 78(5):1107-13. PubMed ID: 21943872
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
Etzioni R; Berry KM; Legler JM; Shaw P
Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
[TBL] [Abstract][Full Text] [Related]
5. Use of prostate-specific antigen testing as a disease surveillance tool following radical prostatectomy.
Trantham LC; Nielsen ME; Mobley LR; Wheeler SB; Carpenter WR; Biddle AK
Cancer; 2013 Oct; 119(19):3523-30. PubMed ID: 23893821
[TBL] [Abstract][Full Text] [Related]
6. Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer.
Nyame YA; Holt SK; Etzioni RD; Gore JL
Cancer; 2023 May; 129(9):1402-1410. PubMed ID: 36776124
[TBL] [Abstract][Full Text] [Related]
7. Intensity of observation with active surveillance or watchful waiting in men with prostate cancer in the United States.
Al Hussein Al Awamlh B; Wu X; Barocas DA; Moses KA; Hoffman RM; Basourakos SP; Lewicki P; Smelser WW; Arenas-Gallo C; Shoag JE
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):395-402. PubMed ID: 35882950
[TBL] [Abstract][Full Text] [Related]
8. Association between PSA values and surveillance quality after prostate cancer surgery.
Chapman CH; Caram MEV; Radhakrishnan A; Tsodikov A; Deville C; Burns J; Zaslavsky A; Chang M; Leppert JT; Hofer T; Sales AE; Hawley ST; Hollenbeck BK; Skolarus TA
Cancer Med; 2019 Dec; 8(18):7903-7912. PubMed ID: 31691526
[TBL] [Abstract][Full Text] [Related]
9. Income inequality and treatment of African American men with high-risk prostate cancer.
Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
[TBL] [Abstract][Full Text] [Related]
10. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
Sarabu N; Dong W; Koroukian SM
Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
[TBL] [Abstract][Full Text] [Related]
12. Hospital racial composition and the treatment of localized prostate cancer.
Pollack CE; Bekelman JE; Liao KJ; Armstrong K
Cancer; 2011 Dec; 117(24):5569-78. PubMed ID: 21692067
[TBL] [Abstract][Full Text] [Related]
13. How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States.
Loeb S; Walter D; Curnyn C; Gold HT; Lepor H; Makarov DV
J Urol; 2016 Sep; 196(3):721-6. PubMed ID: 26946161
[TBL] [Abstract][Full Text] [Related]
14. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
Zanwar P; Lin YL; Kuo YF; Goodwin JS
BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
Mahal BA; Chen YW; Muralidhar V; Mahal AR; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Kim SP; Beard CJ; Martin NE; Trinh QD; Nguyen PL
Ann Oncol; 2017 May; 28(5):1098-1104. PubMed ID: 28453693
[TBL] [Abstract][Full Text] [Related]
16. Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis.
Zeliadt SB; Penson DF; Albertsen PC; Concato J; Etzioni RD
Cancer; 2003 Aug; 98(3):496-503. PubMed ID: 12879465
[TBL] [Abstract][Full Text] [Related]
17. Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test.
Abashidze N; Stecher C; Rosenkrantz AB; Duszak R; Hughes DR
JAMA Netw Open; 2021 Nov; 4(11):e2132388. PubMed ID: 34748010
[TBL] [Abstract][Full Text] [Related]
18. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.
Mariotto AB; Etzioni R; Krapcho M; Feuer EJ
Cancer; 2007 May; 109(9):1877-86. PubMed ID: 17372918
[TBL] [Abstract][Full Text] [Related]
19. The impact of PSA testing frequency on prostate cancer incidence and treatment in older men.
Shao YH; Albertsen PC; Shih W; Roberts CB; Lu-Yao GL
Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):332-9. PubMed ID: 21709691
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.
Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Lago-Hernandez C; Choueiri TK; Elfiky AA; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Lathan CS; Trinh QD; Nguyen PL
J Geriatr Oncol; 2014 Oct; 5(4):352-8. PubMed ID: 24862107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]